Sandra-ChristianeKamper

Partner-in-Charge Frankfurt

(T) 49.69.9726.3939

Connect:

Share

Sandra Kamper has extensive experience, both as outside and in-house counsel, and on some of the most complex, high-profile financing projects, helping clients effectively respond to significant sourcing issues. She handles all aspects of banking and finance matters, in particular corporate finance, real estate finance, and acquisition finance, as well as related practice areas, including fund work. Sandra represents corporate and institutional clients as borrowers and investors and advises clients on structuring, financing, and management of their real estate and other investments. She also has in-depth experience in the restructuring of real estate investments and workouts. She advises on general banking and regulatory matters.

Recent representative transactions include the voluntary public tender offer for all shares of GfK SE by KKR, OM Group's US$1 billion acquisition of Vacuumschmelze GmbH & Co KG and the related financing and refinancing, Goodman European Logistic Funds €800 million refinancing, and the acquisition financing for The Riverside Company projects.

Sandra is Partner-in-Charge of the Firm's Frankfurt Office, where she started her career in 1995. From 1999 to 2000, she was head of legal affairs for Das Werk AG, and she worked at another international law firm from 2000 to 2002.

Experience

  • IPM Independent Portfolio Manager Limited acquires Solone S.r.l.Jones Day advised IPM Independent Portfolio Manager Limited in: (i) the acquisition of Solone S.r.l. by Solar Park 1 Limited; (ii) signing the "Supply and Installation Agreements" for the construction of three solar parks in Troia, Foggia, Italy, and related "Operations and Maintenance Agreements" between Solone S.r.l. and Sociedad Española de Montajes Industriales S.A.; and (iii) financing the construction of the aforementioned solar parks through three financial lease agreements, and related security documents, between Solone S.r.l. and Unicredit Leasing S.p.A.
  • Tokyo Electron participates as major creditor on Qimonda's creditors' committeeJones Day advises Tokyo Electron Limited in connection with the insolvency of Qimonda AG and its subsidiaries.
  • GELF obtains financing for the acquisition of logistics assetsJones Day advised Goodman European Logistics Fund, a pan-European real estate fund that invests in high-quality industrial and logistics properties, in connection with the €737 million (US$1.1 billion) senior term and revolving credit facilities arranged by Eurohypo AG, and The Royal Bank of Scotland plc to finance the acquisition and development of various European logistics assets, including properties let to Kuehne + Nagel.
  • Merz GmbH acquires Pharma Investment HoldingJones Day advised Merz GmbH & Co. KGaA in its acquisition of Pharma Investment Holding S.A. which holds a 100% share in BioteCon Therapeutics GmbH.
  • Procter & Gamble sells European tissue and towel businessJones Day advised The Procter & Gamble Company in the €512 million (US$672 million) sale of its European tissue and towel business to Svenska Cellulosa AB.
  • Riverside sells PPC Insulators to SevesJones Day counseled The Riverside Company in its sale of PPC Insulators, the leading suppliers of low, medium and high voltage insulators to the power and processing industries, to Seves S.p.A., a manufacturer and distributor of glass, porcelain, and composite insulators for power generation and transmission systems, power distribution systems, and electric railways.
  • Mahle GmbH acquires Siemens VDO Automotive's air intake module and air filtration businessJones Day advised Mahle GmbH in its acquisition of Siemens VDO Automotive's air intake module and air filtration business segment for combustion engines.
  • Macquarie Goodman acquires Akeler Holdings for $1.2 billionJones Day advised Macquarie Goodman Management Limited in the £600 million (US$1.2 billion) acquisition, by its managed fund Arlington Business Parks Partnership, of Akeler Holdings S.A.
  • Bayer AG sells GE Bayer Silicones for $604 millionJones Day advised Bayer AG in the €475 million (US$604.4 million) sale of its 49.9% stake in GE Bayer Silicones GmbH & Co. KG, a joint venture with GE, to GE and indirectly/ultimately to Apollo Management L.P.
  • Macquarie Goodman acquires Eurinpro for $451 millionJones Day advised Macquarie Goodman Management Limited in its €352 million (US$451.5 million) acquisition of Eurinpro International SA.
  • Bayer AG acquires Icon GeneticsJones Day advised Bayer AG in the acquisition by its subsidiary Bayer Innovation GmbH of Icon Genetics AG from its founders and certain mostly state-owned venture capital funds.
  • Medical garments manufacturer restructures and refinances debtJones Day advised a leading manufacturer of medical compression therapy garments in connection with the $15.8 million restructuring and refinancing of all the bank debt of the company and its affiliates.
  • Cerberus Partners acquires non-performing loan portfolio from Bayerische LandesbankJones Day advised Cerberus Partners L.P. in its acquisition of a non-performing loan portfolio from Bayerische Landesbank.
    • View All

    December 2017 Newsletters

    EuroResource—Deals and Debt | December 2017

    March 2017 Commentaries

    EuroResource—Deals & Debt

    September 2016 Newsletters

    EuroResource--Deals and Debt

    August 2016 Newsletters

    EuroResource—Deals and Debt

    June 2016 Alerts

    Brexit: United Kingdom Votes to Leave the EU

    June 2016 Newsletters

    EuroResource—Deals and Debt

    April 2016 Newsletters

    EuroResource—Deals and Debt

    October 2015 Newsletters

    EuroResource—Deals and Debt

    June 2015 Newsletters

    EuroResource—Deals and Debt

    March 2015 Newsletters

    EuroResource—Deals and Debt
    View All

    Speaking Engagements

    • März 2009
      JDialog: Distressed M&A im Wege des Debt-Equity Swaps
    • March 2009
      JDialog: Distressed M&A through Debt-Equity Swaps
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.